Matthew Winkler
CIK 1652067 · last filed 2025-07-10
Matthew Winkler is a corporate insider who has filed 9 SEC Form 4 insider transactions across 2 companies since 2015. Across all open-market trades the lifetime net is +$1.0M, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
9
$1.02M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Akoya Biosciences, Inc. (AKYA) Delisted | Director | 984,513 | $1.29 | $1.27M | $1.02M | 5 | 2024-06-05 |
| SYNLOGIC, INC. (MIRN) Delisted | Director | 691,800 | — | — | $0 | 2 | 2016-09-06 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-10 | — | Other (J) | −984,513 | $0 | |
| 2024-06-05 | Akoya Biosciences, Inc. (AKYA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-12 | Akoya Biosciences, Inc. (AKYA) Delisted | Buy (P) | +203,388 | $1.02M | EDGAR |
| 2023-06-05 | Akoya Biosciences, Inc. (AKYA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-03 | Akoya Biosciences, Inc. (AKYA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-25 | Akoya Biosciences, Inc. (AKYA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-09-06 | SYNLOGIC, INC. (MIRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-10-06 | SYNLOGIC, INC. (MIRN) Delisted | Mixed | +802,276 | $0 | EDGAR |
| 2015-09-30 | — | Grant (A) | — | $0 |